Xellia Pharmaceuticals, a manufacturer of specialty anti-infective treatments, said that its manufacturing site in Cleveland, OH is now commercially operational and has released the first anti-infectives manufactured at the site, to be distributed for use by U.S. hospitals.   The anti-infective is the first drug product to be manufactured at the Cleveland site since it was bought by Xellia in 2015 and extensively rebuilt. The state-of-the-art facility is now commercially active after operations ...